KRYS Krystal Biotech, Inc.
$347.00▲ +0.42%
Healthcare
Other
After hours
$347.00▲ +0.00%
Sep 11, 7:30 PM ET
Volume 206.2K
Avg Volume (10D) 225.4K
Key Metrics & Fundamentals
Market Cap
$10.27B
P/E Ratio
43.5
Div Yield
–%
52W Range
141.25 - 382.54
% vs 50 MA
-0.21%
% vs 200 MA
18.37%
RSI-14
48.7
MACD Histogram
-1.2500
Beta (1Y vs SPY)
0.79
Free Cash Flow
$71.22M
Gross Rev
$119.22M
Gross Profit
$112.79M
EBITDA
$59.98M
COGS
$6.44M
Operating Exp
$54.37M
Operating Income
$58.42M
EBIT
$58.42M
Pretax Income
$66.08M
Net Income
$54.77M
EPS (Diluted)
1.79
Price & Volume History
Loading chart…
Recent News
Krystal Biotech Insider Sold Shares Worth $8,983,084, According to a Recent SEC Filing
MT Newswires · Sep 8, 2026 7:53 AM
Krystal Biotech Insider Sold Shares Worth $8,982,986, According to a Recent SEC Filing
MT Newswires · Sep 8, 2026 7:51 AM
Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
Zacks · Sep 3, 2026 3:49 PM
Why Is Amgen (AMGN) Up 8.6% Since Last Earnings Report?
Zacks · Sep 3, 2026 3:30 PM
Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference
GlobeNewswire · Sep 3, 2026 12:00 PM
Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?
Zacks · Sep 2, 2026 3:30 PM
Krystal Biotech Insider Sold Shares Worth $8,227,953, According to a Recent SEC Filing
MT Newswires · Aug 17, 2026 8:01 AM
Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says
MT Newswires · Aug 14, 2026 3:11 PM
Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More
24/7 Wall St. · Aug 14, 2026 11:55 AM
RBC Initiates Krystal Biotech at Outperform, With $400 Price Target
MT Newswires · Aug 14, 2026 10:28 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See KRYS's money flow as a full page
Social Sentiment
No Reddit posts found for KRYS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.